Ken Griffin acquired 16.5 Thousand Theravance Biopharma shares worth $145 Thousand. That's 0.0% of their equity portfolio (4988th largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares seventeen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $418 Thousand, resulting in a loss of 65%.